|
AR134152A2
(es)
|
|
Composiciones sólidas que comprenden un agonista del glp-1 y una sal del ácido n-(8-(2-hidroxibenzoil)amino)caprílico
|
|
BR122022006221A2
(enExample)
|
|
|
|
BR122022015534A2
(enExample)
|
|
|
|
BR122022002102A2
(enExample)
|
|
|
|
AR134182A2
(es)
|
|
Composiciones de ácidos grasos poliinsaturados enriquecidos con dha
|
|
AT524874A5
(enExample)
|
|
|
|
AT524834A2
(enExample)
|
|
|
|
AU2018438767B1
(enExample)
|
|
|
|
AT521543A3
(enExample)
|
|
|
|
AT524266A2
(enExample)
|
|
|
|
AT524961A5
(enExample)
|
|
|
|
BR122022005529A2
(enExample)
|
|
|
|
BR122022016585A2
(enExample)
|
|
|
|
BR212020012832U2
(enExample)
|
|
|
|
BR202018071071U8
(enExample)
|
|
|
|
BE2018C025I2
(enExample)
|
|
|
|
BR202018008879U2
(enExample)
|
|
|
|
BR202018007669U2
(enExample)
|
|
|
|
BR202018006247U2
(enExample)
|
|
|
|
BR202018004136U2
(enExample)
|
|
|
|
BR202018002487U2
(enExample)
|
|
|
|
BR202018002069U2
(enExample)
|
|
|
|
CN304444433S
(enExample)
|
|
|
|
CN304444423S
(enExample)
|
|
|
|
CN304443040S
(enExample)
|
|
|